National Institute of Allergy and Infectious Diseases; Notice of Meeting, 50016 [2015-20330]
Download as PDF
<![CDATA[
50016
Federal Register / Vol. 80, No. 159 / Tuesday, August 18, 2015 / Notices
collect core data across grantees to
examine the extent to which the
Government’s investment has resulted
in achieving OWH-related Healthy
People 2020 priorities and yields
lessons learned upon which to plan
future initiatives related to its mission.
Likely Respondents: The proposed
collection includes plans for interviews
with key staff (project directors, project
coordinators, local evaluators), coalition
members (including chairs and cochairs), and community leaders
connected to the coalitions. These
respondents will also complete online
surveys about their perceptions of the
changes in their community as a result
of coalition activities. Program
participants and other community
members exposed to the coalitions’
activities through social media will also
complete online surveys. Project
directors and local evaluators also
annually provide information to OWH
on their coalition’s functioning, the
status of the cost-effectiveness analysis
for their coalition’s interventions, and
the coalition’s plans for sustainability.
The following table summarizes the
‘‘Total Estimated Annualized Burden—
Hours’’ by form and type of respondent.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
responses per
respondent
Number of
respondents
Form name
Average
burden per
response
(in hrs)
Total burden
hours
1—Key Persons Discussion Guide for Telephone Interviews .........................
2—Key Persons, Coalition Members, and Community Leaders Online Survey ................................................................................................................
3—Coalition Participants and Other Community Members Online Survey .....
4—Grantee Annual Report on Coalition Functioning, Cost-Effectiveness,
and Sustainability Planning ..........................................................................
90
2
1
180
200
510
1
1
20/60
20/60
67
170
10
2
2
40
Total ..........................................................................................................
........................
........................
........................
457
OS specifically requests comments on
(1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Terry S. Clark,
Assistant Information Collection Clearance
Officer.
[FR Doc. 2015–20357 Filed 8–17–15; 8:45 am]
BILLING CODE 4150–33–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSK5VPTVN1PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the AIDS
Research Advisory Committee, NIAID.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
VerDate Sep<11>2014
17:02 Aug 17, 2015
Jkt 235001
Name of Committee: AIDS Research
Advisory Committee, NIAID AIDS Vaccine
Research Subcommittee, NIAID.
Date: September 22, 2015.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: Presentations by invited speakers
to discuss correlates of AIDS vaccine
protection studies in nonhuman primates. In
addition, there will be presentations and
discussion on vaccine-specific HLA–E and
class II-restricted CD8+ cells and their role in
nonhuman primate protection observed with
AIDS vaccines based on CMV vectors.
Place: National Institutes of Health,
Conference Room 1D13, 5601 Fishers Lane,
Rockville, MD 20892.
Contact Person: James A. Bradac, Ph.D.,
Executive Secretary, AVRS, Division of AIDS,
Room 9B60, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9829,
Rockville, MD 20892–9829, 301–435–3754,
jbradac@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 13, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–20330 Filed 8–17–15; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Advisory Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Advisory Board.
Date: September 16, 2015.
Open: 1:00 p.m. to 2:00 p.m.
Agenda: Director’s report and business of
the Board.
Closed: 2:00 p.m. to 3:00 p.m.
Frm 00032
Fmt 4703
Sfmt 4703
E:\FR\FM\18AUN1.SGM
18AUN1
]]>Agencies
[Federal Register Volume 80, Number 159 (Tuesday, August 18, 2015)]
[Notices]
[Page 50016]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-20330]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
AIDS Research Advisory Committee, NIAID.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: AIDS Research Advisory Committee, NIAID AIDS
Vaccine Research Subcommittee, NIAID.
Date: September 22, 2015.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: Presentations by invited speakers to discuss correlates
of AIDS vaccine protection studies in nonhuman primates. In
addition, there will be presentations and discussion on vaccine-
specific HLA-E and class II-restricted CD8+ cells and their role in
nonhuman primate protection observed with AIDS vaccines based on CMV
vectors.
Place: National Institutes of Health, Conference Room 1D13, 5601
Fishers Lane, Rockville, MD 20892.
Contact Person: James A. Bradac, Ph.D., Executive Secretary,
AVRS, Division of AIDS, Room 9B60, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9829, Rockville, MD 20892-9829, 301-
435-3754, jbradac@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 13, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-20330 Filed 8-17-15; 8:45 am]
BILLING CODE 4140-01-P
